This topic contains a solution. Click here to go to the answer

Author Question: An illustration of a non-credible commitment is the promise a. to not increase capacity in a ... (Read 20 times)

WWatsford

  • Hero Member
  • *****
  • Posts: 539
    • Biology Forums!
An illustration of a non-credible commitment is the promise
 a. to not increase capacity in a declining industry
  b. to match a new entrant's discount price
  c. to enter a profitable industry
  d. to restrain output to the quota assigned by a cartel
  e. to exit in the face of projected losses.

Question 2

In the strategic view of bargaining:
 a. You want to improve your opponent's outside options
  b. You want to decrease your outside options
  c. Bargaining is of a prisoner's dilemma game
  d. Bargaining is of a game of 'chicken'



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Bigfoot1984

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

d

Answer to Question 2

d




WWatsford

  • Member
  • Posts: 539
Reply 2 on: Jul 1, 2018
Great answer, keep it coming :)


Bigfoot1984

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Excellent

 

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

Malaria was not eliminated in the United States until 1951. The term eliminated means that no new cases arise in a country for 3 years.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library